T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.

Adenosine deaminase (ADA) deficiency causes severe combined immune deficiency (SCID) by interfering with the metabolism of deoxyadenosine, which is toxic to T lymphocytes at all stages of differentiation. Enzyme replacement with polyethylene glycol-modified ADA (PEG-ADA) has been previously shown to...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Weinberg, K, Hershfield, M S, Bastian, J, Kohn, D, Sender, L, Parkman, R, Lenarsky, C
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1993
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC294890/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8349799/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116626
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!